Entries by

Ascencia raises seed capital investment for further development of their lab digitization technology

23/10/2023 in /by

UTRECHT, Netherlands – Utrecht Health Seed Fund and imec.istart invest 300K+ euros in Ascenscia.   Ascenscia is an emerging tech startup in laboratory automation. Their product comprises a highly specialized voice assistant for scientific laboratories. It understands scientific terminologies and workflows efficiently and enables scientists to communicate with other lab systems by voice. Ascenscia’s goal […]

Synerkine Pharma secures EUR 12.1 million to accelerate novel pain therapeutics towards clinical proof-of-concept

12/10/2023 in /by

Our new portfolio company Synerkine Pharma, a biopharmaceutical company creating innovative pain solutions. Leiden, the Netherlands, October 12, 2023 ·     Flerie leads Series A extension with other existing investor Thuja Capital participating and NEW investors InnovationQuarter Capital and Utrecht Health Seed Fund joining the round ·     Complementing the Series a extension, Synerkine has received A […]

Academic Startup Competition – 4th Edition – APPLICATIONS OPEN

10/10/2023 in /by

Dear Founder, We are excited to announce that the applications for the 4th edition of the Academic Startup Competition are open! The Academic Startup Competition (ASC) is a joint initiative of Techleap, UNL, NFU, NAE, UTwente, VU and EZK. The competition offers a curated batch of 20 selected academic startups the chance to showcase themselves […]

UMC Utrecht spin-out Cordys Analytics secures investment for improved early detection of heart disease.

03/10/2023 in /by

UTRECHT, Netherlands – 3 oktober 2023 LUMO Labs, ROM Utrecht Region and Utrecht Health Seed Fund are investing 900,000 euros in Cordys Analytics. The startup is a Dutch healthtech spin-out from the University Medical Center Utrecht (UMCU) and incubated at UtrechtInc.   Cordys Analytics’ AI-powered software platform for electrocardiogram analysis (AI-ECG software) offers a new […]

Phlox Therapeutics Raises Additional Seed Funding to Further Develop RNA Therapies for Genetic Laminopathies

18/08/2023 in , , , , , , , , /by

A very warm welcome to new portfolio company Phlox Therapeutics, a private biotechnology company specializing in developing innovative RNA-therapeutics for rare genetic cardiomyopathies. Below the press relaese; • Phlox Therapeutics raises additional seed funding to develop RNA therapies for genetic laminopathies • Funds will advance the company’s lead program into preclinical development 08 May 2023, Naarden, […]

Valentina Vignali appointed as Investment Associate

18/07/2023 in /by

Utrecht Holdings welcomes Valentina Vignali to the team. Valentina is about to obtain a PhD in Biomedical Engineering from the University of Groningen and brings experience from working in academia and venture capital. At her previous roles she conducted fund and direct investments due diligence. Valentina will support the business development and investment team of […]

Looking for an Investment Analyst

18/04/2023 in /by

Bringing new innovations to the market; that is the challenge that we, together with researchers from Utrecht University and UMC Utrecht, face every day at Utrecht Holdings. The goal of our team of 15 expert and enthusiastic employees, is to maximize the impact of academic research on people, society and the (local) economy. Would you […]

Moveshelf raises €1.7M to accelerate growth and international sales of its Information System for Movement Disorders

06/10/2022 in /by

Utrecht, The Netherlands Moveshelf is a private digital health company which supplies a novel information system for movement and musculoskeletal disorders. With Moveshelf’s certified Software-as-a-Service, healthcare organizations unlock use of mobility measurements in clinical settings, store data from cameras and wearables in one secure place and allow their medical teams to easily visualize results and […]

Cresco Spine closes seed investments to develop innovative dynamic surgical therapy for scoliosis

27/06/2022 in /by

June 24, 2022 – Utrecht, the Netherlands Cresco Spine, a new player in the spinal arena and a spin-off of the University Medical Center Utrecht (the Netherlands), today announced that it raised seed investments from InSpine and Utrecht Health Seed Fund (UHSF) to continue its development of their unique surgical spinal correction platform “Dynamic Implant […]

TargED Biopharmaceuticals raises EUR 39 Million in Series A financing to bring groundbreaking thrombolytic treatment to patients

22/02/2022 in /by

Our portfolio company Targed Biopharmaceuticals raised Series A financing of € 39 million to develop improved treatments for thrombotic diseases. The financing was co-led by Andera Partners, Fund+, Hadean Ventures, Inkef Capital and Sunstone Life Science Ventures, and joined by existing investors First, Curie Capital and UHSF.   Congratulations to the whole TargED team! Please […]